Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Original Research

Published on 18 Nov 2022

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jinbao Zhang
Meiling Chen
Chuanfa Fang
Peng Luo

Frontiers in Oncology

doi 10.3389/fonc.2022.1052132

5,006 views
9 citations

Original Research

Published on 18 Nov 2022

Comparison of laparoscopic and open pancreaticoduodenectomy for the treatment of distal cholangiocarcinoma: A propensity score matching analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuwen Zhu
Guangchen Zu
Di Wu
Yue Zhang
Yang Yang
Han Wu
Xuemin Chen
Weibo Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1057337

2,334 views
4 citations

Review

Published on 17 Nov 2022

Review of the endocrine organ–like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ying-Chun Yu
Azaj Ahmed
Hsueh-Chou Lai
Wei-Chung Cheng
Juan-Chern Yang
Wei-Chun Chang
Lu-Min Chen
Yan-Shen Shan
Wen-Lung Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.1057930

3,975 views
3 citations

Original Research

Published on 17 Nov 2022

Survival benefit of primary tumor resection for gastric cancer with liver metastasis: A propensity score-matched, population-based study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jiayan Wu
Jiandong Yu
Zhiping Chen
Hongquan Zhu
Chengrui Zhong
Yongling Liang
Ziyan Mai
Zejin Lin
Yunle Wan
Guolin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1039086

2,120 views
10 citations

Original Research

Published on 17 Nov 2022

Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jing Chen
Yuhong Luo
Xiaoxue Xi
Haixia Li
Shufen Li
Lei Zheng
Dinghua Yang
Zhen Cai

Frontiers in Oncology

doi 10.3389/fonc.2022.931140

3,540 views
13 citations

Original Research

Published on 16 Nov 2022

PD-1 inhibitors plus nab-paclitaxel-containing chemotherapy for advanced gallbladder cancer in a second-line setting: A retrospective analysis of a case series

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Sirui Tan
Jing Yu
Qiyue Huang
Nan Zhou
Hongfeng Gou

Frontiers in Oncology

doi 10.3389/fonc.2022.1006075

1,955 views
5 citations

Systematic Review

Published on 14 Nov 2022

Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: A systematic review and meta-analysis of propensity score-matched studies

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Shi Wang
Guanxiong Ye
Jun Wang
Shengqian Xu
Qiaoping Ye
Hailin Ye

Frontiers in Oncology

doi 10.3389/fonc.2022.939877

2,597 views
10 citations

Original Research

Published on 11 Nov 2022

Development and Validation of a nomogram for forecasting survival of alcohol related hepatocellular carcinoma patients

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tao Yan
Chenyang Huang
Jin Lei
Qian Guo
Guodong Su
Tong Wu
Xueyuan Jin
Caiyun Peng
Jiamin Cheng
Linzhi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.976445

2,917 views
1 citation

Original Research

Published on 11 Nov 2022

Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration in vitro

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuan Guo
Hong Tao Hu
Shi Jun Xu
Wei Li Xia
Yan Zhao
Xiao Hui Zhao
Wen Bo Zhu
Fang Ting Li
Hai Liang Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1023801

2,478 views
6 citations

Original Research

Published on 10 Nov 2022

Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Di Zhu
Kun Ma
Wei Yang
Hai-Feng Zhou
Qi Shi
Jian-Wu Ren
Yu-Guan Xie
Sheng Liu
Hai-Bin Shi
Wei-Zhong Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1057560

2,734 views
13 citations

Original Research

Published on 10 Nov 2022

Intrahepatic biliary cystadenoma: Confusion, experience, and lessons learned from our center

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yongguang Yang
Weihuang Chen
Haiqiang Cen
Zuobiao Li
Xiaoqing Di
Yongjun Wu
Lijuan Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1003885

3,289 views
4 citations

Original Research

Published on 10 Nov 2022

Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Thorben Fründt
Johann von Felden
Jenny Krause
Asmus Heumann
Jun Li
Sabine Riethdorf
Klaus Pantel
Samuel Huber
Ansgar W. Lohse
Henning Wege

Frontiers in Oncology

doi 10.3389/fonc.2022.941660

2,863 views
9 citations

Original Research

Published on 10 Nov 2022

Postoperative outcomes of resectable periampullary cancer accompanied by obstructive jaundice with and without preoperative endoscopic biliary drainage

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tanawat Pattarapuntakul
Tummarong Charoenrit
Nisa Netinatsunton
Thanapon Yaowmaneerat
Thakerng Pitakteerabundit
Bancha Ovartlarnporn
Siriboon Attasaranya
Thanawin Wong
Naichaya Chamroonkul
Pimsiri Sripongpun

Frontiers in Oncology

doi 10.3389/fonc.2022.1040508

1,892 views
6 citations

Editorial

Published on 08 Nov 2022

Editorial: Identification of novel biomarkers for pancreatic and hepatocellular cancers

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Laura Matteucci
Ilario Giovanni Rapposelli
Alessandro Passardi

Frontiers in Oncology

doi 10.3389/fonc.2022.1056002

1,089 views

Original Research

Published on 08 Nov 2022

Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Li-ting Wang
Qiu-ling Zeng
Shao-lan Jiang
Zhen-yu Chen
Xiao-ling Wang
Ling Li
Xiaolong Li

Frontiers in Oncology

doi 10.3389/fonc.2022.987481

2,980 views
4 citations

Original Research

Published on 02 Nov 2022

Development and validation of a prognostic nomogram for extrahepatic bile duct adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Shiyao Zhang
You Cui
Xinyu Zhao
Qi Zhang
Chunqiang Li
Qianpeng Huang
Gang Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.950335

1,338 views
1 citation